Actively Recruiting

Age: 35Years - 65Years
All Genders
Healthy Volunteers
NCT05156736

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Led by Tabba Heart Institute · Updated on 2023-04-07

2000

Participants Needed

1

Research Sites

294 weeks

Total Duration

On this page

Sponsors

T

Tabba Heart Institute

Lead Sponsor

G

Getz Pharma

Collaborating Sponsor

AI-Summary

What this Trial Is About

Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk is higher in Pakistanis than in Indians-the two largest SA groups. Pakistan is the 5th most populous country in the world, and despite these concerning trends, so far there has been a scarcity of large studies evaluating the prevalence of cardiovascular risk factors and subclinical coronary atherosclerosis in young-to-middle-aged Pakistanis. Also, there is currently no cardiovascular risk score specifically tailored to younger Pakistani men and women. The PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT) aims at addressing these important gaps. PAK-SEHAT is an ongoing prospective cohort study that will enroll 2,000 asymptomatic Pakistani men aged 35 to 60 years and women aged 35 to 65 years from the general population, free of clinically overt cardiovascular disease. Participants will undergo a comprehensive baseline exam including coronary computed tomography angiography, and will be followed for incident events and repeat testing for 5 years. PAK-SEHAT will allow determining the prevalence, severity, determinants, and prognostic significance of early atherosclerosis in apparently healthy young-to-middle-aged Pakistanis. This knowledge can help inform primordial and primary prevention strategies, enhanced cardiovascular risk stratification, and potential plaque-screening approaches in Pakistan, all of which can ultimately help reduce the burden of CHD in the country. In this report investigators describe the rationale, objectives, methods, and discuss the potential implications of the PAK-SEHAT study.

CONDITIONS

Official Title

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Who Can Participate

Age: 35Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Native Pakistani
  • Men aged 35-60 years and women aged 35-65 years
  • Willing to consent to participation
Not Eligible

You will not qualify if you...

  • eGFR less than 60 ml/min/1.73m2
  • Pregnant women
  • History of stroke or myocardial infarction (including CABG or PCI)
  • History of peripheral arterial disease
  • Weight more than 102 Kg
  • Any active malignancy
  • Known contraindication to contrast used in cardiac CT angiography
  • Expected to move away from residential area within 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tabba Heart Institute

Karachi, Sindh, Pakistan, 74500

Actively Recruiting

Loading map...

Research Team

B

Bashir Hanif, FSCAI

CONTACT

G

Ghazal Peerwani, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here